Chromatin closes new financing round

Date:01-16-2014

Chromatin, a biotechnology company based in Chicago, USA, announced the first closing of its Series E financing round, expected to total $36 million.

Wood Creek Capital Management, an investment manager focused on investing in real assets and intellectual property, including agricultural resources, led the round. Other participants included GE Capital, Equity, as well as funds that had participated in earlier rounds of financing.  

Chromatin is bringing a range of innovations to sorghum — a high-yielding, nutrient-efficient, and drought tolerant crop that can meet the growing global demand for sustainable food, feed and biomass production.